Programs Search and Views Navigation
June 2020
- ONLINE ON-DEMAND
Collaborating to Overcome Lifelong Challenges in Hemophilia A: Prophylaxis, Inhibitors, and Treatment Burden – A Gather-ed Activity
This online CME program was developed to help clinicians create personalized treatment plans, utilize strategies to improve adherence, and implement plans for management of inhibitors in patients with hemophilia A. This Gather-ed is supported with self-study modules, live web discussions, and collaborative group tasks. The intent is to provide participants with an opportunity to improve their understanding of clinical information and to share experiences with peers. Online Gather-ed Peer-to-Peer Learning and Mentoring Initiative. Here is the link to sign up…
Find out more »November 2020
- ONLINE ON-DEMAND
Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care – Gather-ed Activity
The goal of this Gather-ed experience is to summarize the latest clinical evidence and recommendations for early diagnosis and aggressive management of MS. This initiative consists of self-study modules and live group discussions that briefly review relevant clinical trial findings and addresses questions clinicians commonly face in their practice. Here is the link to sign up with additional details. Once on the platform, pick a group to enroll in. The groups will be kicking off in early to mid-January. Don’t wait,…
Find out more »- ONLINE ON-DEMAND
Moving the Needle: Collaborative Strategies to Overcome Barriers to Insulin Initiation and Adherence – Gather-ed Activity
Are you confident initiating and managing insulin in your clinical practice? With the number of adults with type 2 diabetes estimated to increase to over 60 million by 2060, more patients will require insulin and more strain will be placed on clinicians in the health care system. This educational activity will be delivered via an innovative online platform and led by faculty experts in diabetes using virtual small groups of learners to drive discussion and learning through assessments, self-study modules,…
Find out more »January 2021
- ONLINE ON-DEMAND
Advances in the Multidisciplinary Care of Patients with Tenosynovial Giant Cell Tumor – Gather-ed Activity
Tenosynovial giant cell tumor (TGCT), a rare, nonmalignant tumor, arises from synovium in joints, bursae, and tendon sheaths. The diffuse type often presents aggressively, with high recurrence rates following surgery. The FDA recently approved the first medication for adult patients with symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery. Individualized treatment plans should be created for patients by evaluating the benefits and risks of surgery and medications, as well as the type…
Find out more »April 2021
- ONLINE ON-DEMAND
Accelerating New Standards of Oncology Care Amidst the Global Pandemic: Operational, Clinical, and Interpersonal Considerations – Gather-ed
The COVID-19 pandemic has significantly affected nearly every aspect of oncological practice because of the increased risk to patients with cancer and the impact on health care resources. This has led to rapid changes in when, where, and how to provide diagnostic procedures, treatment, and follow-up care. There is an urgent need to provide cancer care professionals with guidance, training, and support as they respond to unprecedented challenges in maintaining high-quality patient care. This activity will be delivered via…
Find out more »June 2021
- ONLINE ON-DEMAND
A Multidisciplinary Team Approach to Patient-Centric Management of Fabry Disease – Gather-ed
Patients with Fabry disease have a significantly shorter life expectancy compared to the general population, often due to cardiac or renal complications of this rare disease. There are only 2 approved therapies for Fabry disease—enzyme replacement therapy and chaperone therapy. Management of Fabry disease and its complications is a rapidly evolving field with ongoing developments, from recent guideline recommendations to new data on approved therapies to promising clinical trials on investigational therapies. Timely and proper management is essential to slow…
Find out more »